Condition
Adolescent Schizophrenia
Total Trials
1
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
1 treatments under study, led by Aripiprazole
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
100.0%
1 terminated out of 1 trials
Success Rate
0.0%
-86.6% vs benchmark
Late-Stage Pipeline
100%
1 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results0
Data Visualizations
Phase Distribution
1Total
Phase 3 (1)
Trial Status
Terminated1
Clinical Trials (1)
Research Network
Common Treatments
- Aripiprazole1
Active Sponsors
- Otsuka Pharmaceutical Development & Commercialization, Inc.1
Top Investigators
Otsuka Pharmaceutical Development & Commercialization, Inc.
Related Conditions
- Child Or Adolescent Bipolar I Disorder Manic Or Mixed Episode With Or Without Psychotic Features1